Smart Insulin Pen Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

Smart Insulin Pen Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
The increasing diabetic population across the world seeks convenient solutions for
diabetics’ management that are easy to recall and document insulin dosages as per
blood sugar level of patients. Smart solutions can provide accurate diabetic
management data in a timely fashion so that healthcare professionals could interpret
pragmatic results based on the data and recommend appropriate treatment.
Insulin pens with smart connectivity are a major breakthrough in the era of
digitization and innovation. Smart insulin pens not just ensure error-free dosage but
also are capable of notifying patients and the healthcare professionals about missed
dosages during treatment. Need for automatic painless insulin dose transfer to
diabetic patients, efficient management of data, increased investment in R&D of
smart connectivity insulin pens, rapid technological advancements are major factors
enabling overall growth in smart insulin pen market.
The global smart insulin pen market is expected to surpass $115 million by 2026 end
and speculated to register CAGR of 10.2% during the forecast period from 2019 to
2026.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=13&page=requestsample
Global Smart Insulin Pen Market, by Product Type:
• Bluetooth-enabled Smart Insulin Pen
• USB Connected Smart Insulin Pen
Bluetooth-enabled smart insulin pen segment is experiencing greater demand than
ever due to focus innovation and digitization across the healthcare sector. Injuries
during insulin injection using the traditional way of needles can cause bruising and
may be difficult to heal in diabetic patients. Bluetooth –enabled and USB connected
smart insulin pens provide an effectively painless alternative for insulin dosage
administrations. Although both the product type will continue to be the most
popular portable self-injecting devices, alternatives like insulin patches, insulin
pumps will pose challenges in the growth of smart insulin pen market. It is worth
investing in manufacturing innovatively designed disposable smart insulin pens in the
near future as they can potentially provide necessary market differentiation in the
forecasted period.
Global Smart Insulin Pen Market, by Indication Type:
• Type I Diabetes
• Type II Diabetes
Type I Diabetes in kids is a highly alarming issue in various parts of the world due to
reasons like malnutrition, obesity and genetic disorders. Type I diabetes is prevalent
among population under 40 while 90% Type II diabetes patients are aged above 50.
Global smart insulin pen market is highly penetrated amongst Type I diabetic
patients and will continue to demonstrate lucrative CAGR in Type I diabetes
indication type segment during the forecasted period.
Global Smart Insulin Pen Market, by Sales Channel:
• Retail Pharmacies
• e-Commerce
• Hospital
• Clinics
Global Smart Insulin Pen Market, by Region:
• Europe
• North America
• APAC
• Latin America
• Rest of World
Asia Pacific region factored as the most lucrative market for smart insulin pen
manufacturers due to high prevalence. North America and Europe smart insulin pen
markets account dominant share in the global market due to high adoption among
end users.
Purchase a Copy of this Premium Research Report & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=13&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global smart insulin pen market on
the basis of product type, indication type, sales channel and region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1. Introduction
1.1. Scope and Objective
1.2. Assumptions and Acronyms
1.3. Forecast Factors
1.4. Research Methodology
2.
Executive Summary
2.1. Industry Cluster Analysis
2.2. Competition Matrix
2.3. Strategies Recommendations
3. Market Definition
3.1. Report Scope (Inclusions & Exclusions)
3.2. Market Segmentation
4.
Global Smart Insulin Pen Market Overview
4.1. Global Smart Insulin Pen Market Revenue (USD Mn)
5.
Key Inclusions
5.1. Porter’s Five Force analysis
5.2. Market Dynamics
5.3. Industry Trends
5.4. Regulatory Guidelines
5.5. Opportunities in Smart Insulin Pen
6.
Competition Dynamics
6.1. Company Share Analysis (2018)
6.2. Top 10 Product Pricing by Region
7. Global Smart Insulin Pen Market Revenue (USD Mn), 2018-2026 by Product
Type
7.1. Key Market Findings
7.2. Long Term ROI Segments
7.3. Revenue Opportunity Influencing Factors
7.4. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 20182026
7.4.1
Bluetooth-enabled Insulin Pen
7.4.2
USB connected pens
8.
Global Smart Insulin Pen Market Revenue (USD Mn), 2018-2026 by Indication
8.1. Key Market Findings
8.2. Long Term ROI Segments
8.3. Revenue Opportunity Influencing Factors
8.4. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 20182026
8.4.1
Type I diabetes
8.4.2
Type II diabetes
9. Global Smart Insulin Pen Market Revenue (USD Mn), 2018-2026 by Sales
Channel
9.1. Key Market Findings
9.2. Long Term ROI Segments
9.3.
Revenue Opportunity Influencing Factors
9.4. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
9.4.1
Retail Pharmacies
9.4.2
Hospital
9.4.3
Clinics
10. Global Smart Insulin Pen Market Revenue (USD Mn), 2018-2026 by Region
10.1.Key Market Findings
10.2.Long Term ROI Segments
10.3.Revenue Opportunity Influencing Factors
10.4.Market Revenue (USD Mn) Assessment and Forecast by Region,2026
10.4.1 North America
10.4.2 Latin America
10.4.3 Europe
10.4.4 Asia Pacific
10.4.5 Rest of world
11. North America Smart Insulin Pen Market Revenue (US$ Mn), 2018-2026
11.1. Key Market Findings
11.2. Long Term ROI Segments
11.3. Revenue Opportunity Influencing Factors
11.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
11.4.1 US
11.4.2 Canada
11.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
11.5.3 Bluetooth-enabled Insulin Pen
11.5.4 USB connected pens
11.6. Market Revenue (USD Mn) Assessment and Forecast by Indication,
2018-2026
11.6.5 Type I diabetes
11.6.6 TypeII diabetes
11.7. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
11.7.7 RetailPharmacies
11.7.8 Hospital
11.7.9 Clinics
12. Latin America Smart Insulin Pen Market Revenue (US$ Mn), 2018-2026
12.1. Key Market Findings
12.2. Long Term ROI Segments
12.3. Revenue Opportunity Influencing Factors
12.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Rest of Latin America
12.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
12.5.5 Bluetooth-enabled Insulin Pen
12.5.6 USB connected pens
12.6. Market Revenue (USD Mn) Assessment and Forecast by Indication,
2018-2026
12.6.7 Type I diabetes
12.6.8 TypeII diabetes
12.7. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
12.7.9 RetailPharmacies
12.7.10 Hospital
12.7.11 Clinics
13. Europe America Smart Insulin Pen Market Revenue (US$ Mn), 2018-2026
13.1. Key Market Findings
13.2. Long Term ROI Segments
13.3. Revenue Opportunity Influencing Factors
13.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
13.4.1 Germany
13.4.2 France
13.4.3 Spain
13.4.4 UK
13.4.5 Russia
13.4.6 Poland
13.4.7 Rest of Europe
13.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
13.5.8 Bluetooth-enabled Insulin Pen
13.5.9 USB connected pens
13.6. Market Revenue (USD Mn) Assessment and Forecast by Indication,
2018-2026
13.6.10 Type I diabetes
13.6.11 TypeII diabetes
13.7. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
13.7.12 RetailPharmacies
13.7.13 Hospital
13.7.14 Clinics
14. Asia Pacific America Smart Insulin Pen Market Revenue (US$ Mn), 2018-2026
14.1. Key Market Findings
14.2. Long Term ROI Segments
14.3. Revenue Opportunity Influencing Factors
14.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
14.4.1 Emerging Asia
14.4.1.1
China
14.4.1.2
India
14.4.1.3
ASEAN-5
14.4.1.4
Rest of Emerging Asia
14.4.2 Japan
14.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
14.5.3 Bluetooth-enabled Insulin Pen
14.5.4 USB connected pens
14.6. Market Revenue (USD Mn) Assessment and Forecast by Indication,
2018-2026
14.6.5 Type I diabetes
14.6.6 TypeII diabetes
14.7. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
14.7.7 RetailPharmacies
14.7.8 Hospital
14.7.9 Clinics
15. Rest of World America Smart Insulin Pen Market Revenue (US$ Mn), 2018-2026
15.1. Key Market Findings
15.2. Long Term ROI Segments
15.3. Revenue Opportunity Influencing Factors
15.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
15.4.1 Middle East
15.4.2 South Africa
15.4.3 North Africa
15.4.4 Rest of World
15.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
15.5.5 Bluetooth-enabled Insulin Pen
15.5.6 USB connected pens
15.6. Market Revenue (USD Mn) Assessment and Forecast by Indication,
2018-2026
15.6.7 Type I diabetes
15.6.8 TypeII diabetes
15.7. Market Revenue (USD Mn) Assessment and Forecast by Sales
Channel, 2018-2026
15.7.9 RetailPharmacies
15.7.10 Hospital
15.7.11 Clinics
16. Company Profiles
16.1. Competition Landscape
16.2. Global Company Share (USD Mn) Overview, 2018
16.3. Company Profiles
16.3.1 Novo Nordisk
16.3.1.1
Corporate Overview
16.3.1.2
Financial Performance
16.3.1.3
Peer Comparison & 3C marketing equation
16.3.1.4
Company Strategy & Channel Management
16.3.2 Companion Medical
16.3.2.1
Corporate Overview
16.3.2.2
Financial Performance
16.3.2.3
Peer Comparison & 3C marketing equation
16.3.2.4
Company Strategy & Channel Management
16.3.3 Dexcom
16.3.3.1
Corporate Overview
16.3.3.2
Financial Performance
16.3.3.3
Peer Comparison & 3C marketing equation
16.3.3.4
Company Strategy & Channel Management
16.3.4 Abbott Diabetes Care
16.3.4.1
Corporate Overview
16.3.4.2
Financial Performance
16.3.4.3
Peer Comparison & 3C marketing equation
16.3.4.4
Company Strategy & Channel Management
16.3.5 Sanofi S.A.
16.3.5.1
Corporate Overview
16.3.5.2
Financial Performance
16.3.5.3
Peer Comparison & 3C marketing equation
16.3.5.4
Company Strategy & Channel Management
16.3.6 Eli Lilly
16.3.6.1
Corporate Overview
16.3.6.2
Financial Performance
16.3.6.3
Peer Comparison & 3C marketing equation
16.3.6.4
Company Strategy & Channel Management
17. Research Sources & Primary Verbatim
Inquire further details about this report at: sales@futurewiseresearch.com
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com

The increasing diabetic population across the world seeks convenient solutions for diabetics’ management that are easy to recall and document insulin dosages as per blood sugar level of patients. Smart solutions can provide accurate diabetic management data in a timely fashion so that healthcare professionals could interpret pragmatic results based on the data and recommend appropriate treatment.

Download Report